Accessibility Menu
 

Hims & Hers (HIMS +0.79%) announced the details of a $350 million debt raise today, and it will fund growth plans and add significant risk to the business. Either the debt will be converted to stock, diluting shareholders, or it will require cash to be paid back.

In this video, I explain the mechanics of the debt and capped call transaction and why Hims & Hers has limited time to prove to the market that it's a growth company again.

*Stock prices used were mid-day prices of May 19, 2026. The video was published on May 19, 2026.

Read Next

About the Author

Travis Hoium
Travis Hoium is a contributing Motley Fool stock market analyst covering solar energy, technology, and growth stocks. Before The Motley Fool, Travis was a mechanical engineer at 3M and founded a virtual reality company. He holds a bachelor’s degree in mechanical engineering and a master’s degree in business administration from the University of Minnesota.
TMFFlushDraw
X@travishoium

Travis Hoium has positions in Hims & Hers Health. The Motley Fool has positions in and recommends Hims & Hers Health. The Motley Fool has a disclosure policy. Travis Hoium is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.

Stocks Mentioned

Hims & Hers Health Stock Quote
Hims & Hers Health
NYSE: HIMS
$22.47
(+0.79%)+$0.18

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services